Hudson Bay Capital Management
MCRB icon

Hudson Bay Capital Management’s Seres Therapeutics MCRB Stock Holding History

Hudson Bay Capital Management’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50,249
Closed -$727K – 972
2024
Q2 		$727K Sell
50,249
-221,001
-81% -$3.69M ﹤0.01% 623
2024
Q1 		$4.2M Buy
271,250
+55,230
+26% +$1.19M 0.02% 335
2023
Q4 		$6.05M Buy
216,020
+116,030
+116% +$3.05M 0.04% 277
2023
Q3 		$4.76M Buy
99,990
+55,990
+127% +$4.27M 0.04% 303
2023
Q2 		$4.22M Buy
44,000
+17,750
+68% +$1.93M 0.03% 343
2023
Q1 		$2.98M Sell
26,250
-2,750
-9% -$297K 0.02% 438
2022
Q4 		$3.25M Buy
29,000
+10,755
+59% +$1.44M 0.03% 484
2022
Q3 		$2.34M Sell
18,245
-17,860
-49% -$1.83M 0.02% 692
2022
Q2 		$2.48M Buy
36,105
+28,605
+381% +$2.46M 0.02% 729
2022
Q1 		$1.07M Buy
7,500
+2,500
+50% +$385K 0.01% 807
2021
Q4 		$833K Sell
5,000
-18,500
-79% -$2.94M 0.01% 818
2021
Q3 		$3.27M Buy
+23,500
New +$4.6M 0.04% 502

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Hudson Bay Capital Management's MCRB Position: Q3 2024 in Review

Hudson Bay Capital Management sold out of Seres Therapeutics (MCRB) in Q3 2024, closing a stake of 50,249 shares — an estimated $727K sold.

Hudson Bay Capital Management first reported a position in MCRB in Q3 2021 and held it in 12 quarters. The position peaked at $6.05M in Q4 2023. 77 funds tracked by Wall St. Rank hold MCRB as of Q3 2024.

  • Hudson Bay Capital Management reported no remaining Seres Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Hudson Bay Capital Management sold 50,249 Seres Therapeutics shares in Q3 2024, an estimated $727K.
  • Hudson Bay Capital Management first reported a position in Seres Therapeutics in Q3 2021 and held it in 12 quarters.
  • Hudson Bay Capital Management's Seres Therapeutics position peaked at $6.05M in Q4 2023.
  • 77 funds tracked by Wall St. Rank held Seres Therapeutics as of Q3 2024.

Based on Hudson Bay Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.